MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II

Journal of Leukocyte Biology

Volumn 82, Issue 3, 2007, Pages 686-699

  Herrmann, Tara L ^a   Agrawal, Reitu S ^a   Connolly, Sean F ^a   McCaffrey, Ramona L ^a   Schlomann, Jamie ^a   Kusner, David J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antigen presentation processing; Cell activation; Signal transduction; Transcription factors

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CALMODULIN; CD1B ANTIGEN; CD34 ANTIGEN; CYSTATIN C; CYSTEINE PROTEINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ADAPTIVE IMMUNITY; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; ENZYME REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADULT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASPASE 3; CATHEPSIN D; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DENDRITIC CELLS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOBLOTTING; LYSOSOMES; MEMBRANE PROTEINS; MONOCYTES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 34548403913     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0107045     Document Type: Article

References (83)

1. Mellman, I., Steinman, R. M. (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258.
2. Mellman, I., Turley, S. J., Steinman, R. M. (1998) Antigen processing for amateurs and professionals. Trends Cell Biol. 8, 231-237.
3. Steinman, R. M., Inaba, K., Turley, S., Pierre, P., Mellman, I. (1999) Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60, 562-567.
4. Herrmann, T. L., Morita, C. T., Lee, K., Kusner, D. J. (2005) Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells. J. Leukoc. Biol. 78, 1397-1407.
5. Colbran, R. J., Brown, A. M. (2004) Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr. Opin. Neurobiol. 14, 318-327.
6. Griffith, L. C., Lu, C. S., Sun, X. X. (2003) CaMKII, an enzyme on the move: regulation of temporospatial localization. Mol. Interv. 3, 386-403.
7. Malik, Z. A., Iyer, S. S., Kusner, D. J. (2001) Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J. Immunol. 166, 3392-3401.
8. Chang, S. T., Linderman, J. J., Kirschner, D. E. (2005) Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. Proc. Natl. Acad. Sci. USA 102, 4530-4535.
9. LeibundGut-Landmann, S., Waldburger, J. M., Reis e Sousa, C., Acha-Orbea, H., Reith, W. (2004) MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 5, 899-908.
10. Villadangos, J. A., Schnorrer, P., Wilson, N. S. (2005) Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207, 191-205.
11. Kitamura, H., Kamon, H., Sawa, S. I., Park, S. J., Katunuma, N., Ishihara, K., Murakami, M., Hirano, T. (2005) IL-6-STAT3 controls intracellular MHC class II αβ dimer level through cathepsin S activity in dendritic cells. Immunity 23, 491-502.
12. Zhou, H., Glimcher, L. H. (1995) Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2, 545-553.
13. Cella, M., Engering, A., Pinet, V., Pieters, J., Lanzavecchia, A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787.
14. Villard, J., Masternak, K., Lisowska-Grospierre, B., Fischer, A., Reith, W. (2001) MHC class II deficiency: a disease of gene regulation. Medicine (Baltimore) 80, 405-418.
15. Schooten, E., Klous, P., van den Elsen, P. J., Holling, T. M. (2005) Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region. Immunogenetics 57, 795-799.
16. LeibundGut-Landmann, S., Waldburger, J. M., Krawczyk, M., Otten, L. A., Suter, T., Fontana, A., Acha-Orbea, H., Reith, W. (2004) Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34, 1513-1525.
17. De Lerma Barbaro, A., Procopio, F. A., Mortara, L., Tosi, G., Accolla, R. S. (2005) The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells. Eur. J. Immunol. 35, 603-611.
18. Zika, E., Ting, J. P. (2005) Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol. 17, 58-64.
19. Marten, A., Ziske, C., Schottker, B., Weineck, S., Renoth, S., Buttgereit, P., Schakowski, F., Konig, S., von Rucker, A., Allera, A., Schroers, R., Sauerbruch, T., Wittig, B., Schmidt-Wolf, I. G. (2001) Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs. Cancer Gene Ther. 8, 211-219.
20. Landmann, S., Muhlethaler-Mottet, A., Bernasconi, L., Suter, T., Waldburger, J. M., Masternak, K., Arrighi, J. F., Hauser, C., Fontana, A., Reith, W. (2001) Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J. Exp. Med. 194, 379-391.
21. Krawczyk, M., Peyraud, N., Rybtsova, N., Masternak, K., Bucher, P., Barras, E., Reith, W. (2004) Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA. J. Immunol. 173, 6200-6210.
22. Iizuka, N., Oka, M. (2004) CIITA methylation and decreased levels of HLA-DR in tumor progression. Br. J. Cancer 91, 813.
23. Tosi, G., Jabrane-Ferrat, N., Peterlin, B. M. (2002) Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters. EMBO J. 21, 5467-5476.
24. Greer, S. F., Harton, J. A., Linhoff, M. W., Janczak, C. A., Ting, J. P., Cressman, D. E. (2004) Serine residues 286, 288, and 293 within the CIITA: a mechanism for down-regulating CIITA activity through phosphorylation. J. Immunol. 173, 376-383.
25. Towey, M., Kelly, A. P. (2002) Nuclear localization of CIITA is controlled by a carboxy terminal leucine-rich repeat region. Mol. Immunol. 38, 627-634.
26. Radosevich, M., Song, Z., Gorga, J. C., Ksander, B., Ono, S. J. (2004) Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Invest. Ophthalmol. Vis. Sci. 45, 3185-3195.
27. Sixt, M., Kanazawa, N., Selg, M., Samson, T., Roos, G., Reinhardt, D. P., Pabst, R., Lutz, M. B., Sorokin, L. (2005) The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22, 19-29.
28. Mohan, J., Hopkins, J., Mabbott, N. A. (2005) Skin-derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure. Immunology 116, 122-133.
29. Moreland, J. G., Bailey, G., Nauseef, W. M., Weiss, J. P. (2004) Organismspecific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. J. Immunol. 172, 426-432.
30. DeLeo, F. R., Allen, L. A., Apicella, M., Nauseef, W. M. (1999) NADPH oxidase activation and assembly during phagocytosis. J. Immunol. 163, 6732-6740.
31. Iyer, S. S., Barton, J. A., Bourgoin, S., Kusner, D. J. (2004) Phospholipases D1 and D2 coordinately regulate macrophage phagocytosis. J. Immunol. 173, 2615-2623.
32. Narendran, P., Elsegood, K., Leech, N. J., Dayan, C. M. (2002) Dendritic cell-based proliferative assays of peripheral T cell responses to tetanus toxoid. Ann. N. Y. Acad. Sci. 958, 170-174.
33. Narendran, P., Elsegood, K., Leech, N. J., Macindoe, W. M., Boons, G. J., Dayan, C. M. (2004) Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes. Immunology 111, 422-429.
34. Jolley, M. E., Wang, C. H., Ekenberg, S. J., Zuelke, M. S., Kelso, D. M. (1984) Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity. J. Immunol. Methods 67, 21-35.
35. St. Louis, D. C., Woodcock, J. B., Fransozo, G., Blair, P. J., Carlson, L. M., Murillo, M., Wells, M. R., Williams, A. J., Smoot, D. S., Kaushal, S., Grimes, J. L., Harlan, D. M., Chute, J. P., June, C. H., Siebenlist, U., Lee, K. P. (1999) Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J. Immunol. 162, 3237-3248.
36. Aronowski, J., Grotta, J. C., Waxham, M. N. (1992) Ischemia-induced translocation of Ca2+/calmodulin-dependent protein kinase II: potential role in neuronal damage. J. Neurochem. 58, 1743-1753.
37. Waxham, M. N., Malenka, R. C., Kelly, P. T., Mauk, M. D. (1993) Calcium/calmodulin-dependent protein kinase II regulates hippocampal synaptic transmission. Brain Res. 609, 1-8.
38. Baton, F., Deruyffelaere, C., Chapin, M., Prod'homme, T., Charron, D., Al-Daccak, R., Alcaide-Loridan, C. (2004) Class II transactivator (CIITA) isoform expression and activity in melanoma. Melanoma Res. 14, 453-461.
39. Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M., Mellman, I. (2003) Activation of lysosomal function during dendritic cell maturation. Science 299, 1400-1403.
40. Chow, A., Toomre, D., Garrett, W., Mellman, I. (2002) Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994.
41. Vella, A., Sartoris, S., Bambara, L., Ortolani, R., Carletto, A., Biasi, D., Stefani, E., Tridente, G. (2002) Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. Inflammation 26, 143-152.
42. Pai, R. K., Askew, D., Boom, W. H., Harding, C. V. (2002) Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. J. Immunol. 169, 1326-1333.
43. Trombetta, E. S., Mellman, I. (2005) Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23, 975-1028.
44. Andersen, E. B. (1994) The Statistical Analysis of Categorical Data, Berlin, Germany; New York, NY, USA, Springer-Verlag.
45. Meyer zum Bueschenfelde, C. O., Unternaehrer, J., Mellman, I., Bottomly, K. (2004) Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. J. Immunol. 173, 6119-6124.
46. Honey, K., Rudensky, A. Y. (2003) Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3, 472-482.
47. Villadangos, J. A., Cardoso, M., Steptoe, R. J., van Berkel, D., Pooley, J., Carbone, F. R., Shortman, K. (2001) MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14, 739-749.
48. Baron, C., Raposo, G., Scholl, S. M., Bausinger, H., Tenza, D., Bohbot, A., Pouillart, P., Goud, B., Hanau, D., Salamero, J. (2001) Modulation of MHC class II transport and lysosome distribution by macrophage-colony stimulating factor in human dendritic cells derived from monocytes. J. Cell Sci. 114, 999-1010.
49. Villadangos, J. A., Driessen, C., Shi, G. P., Chapman, H. A., Ploegh, H. L. (2000) Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM. EMBO J. 19, 882-891.
50. Santambrogio, L., Potolicchio, I., Fessler, S. P., Wong, S. H., Raposo, G., Strominger, J. L. (2005) Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells. Nat. Immunol. 6, 1020-1028.
51. Chow, A. Y., Mellman, I. (2005) Old lysosomes, new tricks: MHC II dynamics in DCs. Trends Immunol. 26, 72-78.
52. Gratama, J. W., Orfao, A., Barnett, D., Brando, B., Huber, A., Janossy, G., Johnsen, H. E., Keeney, M., Marti, G. E., Preijers, F., Rothe, G., Serke, S., Sutherland, D. R., Van der Schoot, C. E., Schmitz, G., Papa, S. (1998) Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 34, 128-142.
53. Wognum, A. W., de Jong, M. O., Wagemaker, G. (1996) Differential expression of receptors for hemopoietic growth factors on subsets of CD34+ hemopoietic cells. Leuk. Lymphoma 24, 11-25.
54. Mahanta, S. K., Scholl, T., Yang, F. C., Strominger, J. L. (1997) Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94, 6324-6329.
55. Cressman, D. E., O'Connor, W. J., Greer, S. F., Zhu, X. S., Ting, J. P. (2001) Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator. J. Immunol. 167, 3626-3634.
56. Leverkus, M., McLellan, A. D., Heldmann, M., Eggert, A. O., Brocker, E. B., Koch, N., Kampgen, E. (2003) MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int. Immunol. 15, 993-1006.
57. Ardeshna, K. M., Pizzey, A. R., Devereux, S., Khwaja, A. (2000) The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96, 1039-1046.
58. Vidalain, P. O., Azocar, O., Servet-Delprat, C., Rabourdin-Combe, C., Gerlier, D., Manie, S. (2000) CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J. 19, 3304-3313.
59. Kikuchi, K., Yanagawa, Y., Iwabuchi, K., Onoe, K. (2003) Differential role of mitogen-activated protein kinases in CD40-mediated IL-12 production by immature and mature dendritic cells. Immunol. Lett. 89, 149-154.
60. Kandilci, A., Grosveld, G. C. (2005) SET-induced calcium signaling and MAPK/ERK pathway activation mediate dendritic cell-like differentiation of U937 cells. Leukemia 19, 1439-1445.
61. Robison, A. J., Bass, M. A., Jiao, Y., MacMillan, L. B., Carmody, L. C., Bartlett, R. K., Colbran, R. J. (2005) Multivalent interactions of calcium/ calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and {α}-actinin-2. J. Biol. Chem. 280, 35329-35336.
62. Hudmon, A., Schulman, H. (2002) Neuronal CA2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu. Rev. Biochem. 71, 473-510.
63. Smith, M. K., Colbran, R. J., Brickey, D. A., Soderling, T. R. (1992) Functional determinants in the autoinhibitory domain of calcium/calmodulin- dependent protein kinase II. Role of His282 and multiple basic residues. J. Biol. Chem. 267, 1761-1768.
64. Omiyi, D., Brue, R. J., Taormina II, P., Harvey, M., Atkinson, N., Young, L. H. (2005) Protein kinase C {β}II peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury. J. Pharmacol. Exp. Ther. 314, 542-551.
65. Villadangos, J. A., Bryant, R. A., Deussing, J., Driessen, C., Lennon-Dumenil, A. M., Riese, R. J., Roth, W., Saftig, P., Shi, G. P., Chapman, H. A., Peters, C., Ploegh, H. L. (1999) Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172, 109-120.
66. Steinman, R. M. (2001) Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 68, 160-166.
67. Pierre, P., Mellman, I. (1998) Exploring the mechanisms of antigen processing by cell fractionation. Curr. Opin. Immunol. 10, 145-153.
68. Hanau, D., Saudrais, C., Haegel-Kronenberger, H., Bohbot, A., De La Salle, H., Salamero, J. (1999) Fate of MHC class II molecules in human dendritic cells. Eur. J. Dermatol. 9, 7-12.
69. Irani, D. N., Anderson, C., Gundry, R., Cotter, R., Moore, S., Kerr, D. A., McArthur, J. C., Sacktor, N., Pardo, C. A., Jones, M., Calabresi, P. A., Nath, A. (2006) Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 59, 237-247.
70. Shin, J-S., Ebersold, M., Pypaert, M., Delamarre, L., Hartley, A., Mellman, I. (2006) Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115-118.
71. Ohmura-Hoshino, M., Matsuki, Y., Aoki, M., Goto, E., Mito, M., Uematsu, M., Kakiuchi, T., Hotta, H., Ishido, S. (2006) Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 177, 341-354.
72. Van Niel, G., Wubbolts, R., Ten Broeke, T., Buschow, S. I., Ossendorp, F. A., Melief, C. J., Raposo, G., van Balkom, B. W., Stoorvogel, W. (2006) Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25, 885-894.
73. Blander, J. M., Medzhitov, R. (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808-812.
74. Li, G., Harton, J. A., Zhu, X., Ting, J. P. (2001) Downregulation of CIITA function by protein kinase A (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines. Mol. Cell. Biol. 21, 4626-4635.
75. Nozell, S., Ma, Z., Wilson, C., Shah, R., Benveniste, E. N. (2004) Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression. J. Biol. Chem. 279, 38577-38589.
76. Schnappauf, F., Hake, S. B., Camacho Carvajal, M. M., Bontron, S., Lisowska-Grospierre, B., Steimle, V. (2003) N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA. Eur. J. Immunol. 33, 2337-2347.
77. McKinsey, T. A., Kuwahara, K., Bezprozvannaya, S., Olson, E. N. (2006) Class II histone deacetylases confer signal responsiveness to the ankyrinrepeat proteins ANKRA2 and RFXANK. Mol. Biol. Cell 17, 438-447.
78. Ellis, J. J., Valencia, T. G., Zeng, H., Roberts, L. D., Deaton, R. A., Grant, S. R. (2003) CaM kinase IIδC phosphorylation of 14-3-3β in vascular smooth muscle cells: activation of class II HDAC repression. Mol. Cell. Biochem. 242, 153-161.
79. McGee, S. L., Hargreaves, M. (2004) Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 53, 1208-1214.
80. Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., Coccia, E. M. (2001) Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166, 7033-7041.
81. Cullell-Young, M., Barrachina, M., Lopez-Lopez, C., Gonalons, E., Lloberas, J., Soler, C., Celada, A. (2001) From transcription to cell surface expression, the induction of MHC class II I-A α by interferon-γ in macrophages is regulated at different levels. Immunogenetics 53, 136-144.
82. Kern, M. J., Stuart, P. M., Omer, K. W., Woodward, J. G. (1989) Evidence that IFN-γ does not affect MHC class II gene expression at the posttranscriptional level in a mouse macrophage cell line. Immunogenetics 30, 258-265.
83. De Lerma Barbaro, A., Frumento, G., Procopio, F. A., Accolla, R. S. (2005) MHC immunoevasins: protecting the pathogen reservoir in infection. Tissue Antigens 66, 2-8.